Main Research Interest is the development of effective, non-toxic treatments for chronic diseases, especially autism, diabetes, and cancer. Metabolic optimization to address the root cause of diseases. Identifying and improving factors associated with neurometabolic and proliferative disorders. Identifying and changing the biochemical conditions that promote, develop, and sustain the malignant state can produce inhibition of malignant cell proliferation, increase aerobic metabolism and achieve re-differentiation possibly with mitochondrial optimization.  Also interested in the development of non-toxic therapeutic strategies that enhance the effectiveness of other treatments or that reduce their toxicity. High dose Ascorbic acid, lipoic acid, acetyl L-Carnitine, Coenzyme Q10, magnesium and phospholipids.